Apriglim-MV 1/2
Composition
Glimepiride 1/2 mg + Metformin 500 mg ER + Voglibose 0.2 mg Tablets
Description
APRIGLIM MV is indicated in the treatment of patients with type 2 diabetes mellitus when diet, exercise and the therapy with two agents do not result in adequate glycemic control. APRIGLIM MV should be given once daily before a full meal. Therapy should be started with APRIGLIM MV one tablet daily based on previous drug treatment and glycemic status of the patient.
APriglim-MV 103/203/303
Composition
Glimepiride 1/2/3 mg + Metformin 500 mg ER + Voglibose 0.3 mg Tablets
Description
APRIGLIM MV is indicated in the treatment of patients with type 2 diabetes mellitus when diet, exercise and the therapy with two agents do not result in adequate glycemic control. APRIGLIM MV should be given once daily before a full meal. Therapy should be started with APRIGLIM MV one tablet daily based on previous drug treatment and glycemic status of the Patients.
Apriglim 1/2/3/4
Composition
Glimepiride 1/2/3/4 mg Tablets
Description
APRIGLIM is indicated as an adjunct to diet and exercise to lower the blood glucose in patients with non-insulin dependant (type-II) diabetes mellitus whose hyperglycemia cannot be controlled by diet and exercise alone. Glimepiride should be administered with breakfast or the first main meal of the day. The recommended starting dose of Glimepiride is 1 mg or 2 mg once daily.
Apriglim-M 0.5
Composition
Glimepiride 0.5 mg + Metformin 500 mg ER Tablets
Description
The use FDC of Metformin Hydrochloride SR and Glimepiride in the management of type 2 diabetes should be individualized on the basis of effectiveness and tolerability. Improves glycemic control with no reports of hypoglycemia or weight gain.
Apriglim-Mf 1/2/3
Composition
Glimepiride 1/2/ mg + Metformin 1000 mg ER Tablets
Description
APRIGLIM MF is indicated in the treatment of patients with type 2 diabetes mellitus when diet, exercise and the single agent do not result in adequate glycemic control. APRIGLIM MF should be given once daily with a full meal & should be started at a low dose.
Apriglim-M 1/2/3/4
Composition
Glimepiride 1/2/3/4 mg + Metformin 500 mg ER Tablets
Description
APRIGLIM M is indicated in the treatment of patients with type 2 diabetes mellitus when diet, exercise and the single agent do not result in adequate glycemic control. The use FDC of Metformin Hydrochloride SR and Glimepiride in the management of type 2 Diabetes should be individualized on the basis of effectiveness and tolerability. APRIGLIM M should be given once daily with a full meal.